In situ saphenous vein bypass grafting - still first line treatment? A prospective study comparing surgical results between diabetic and non-diabetic populations

Vasa - Journal of Vascular Diseases

Volumn 39, Issue 1, 2010, Pages 59-65

  Fransson, T ^a   Thorne J ^b  

^a KALMAR COUNTY HOSPITAL   (Sweden)

^b HELSINGBORG HOSPITAL   (Sweden)

Author keywords

Diabetes mellitus; Peripheral arterial disease

Indexed keywords

AGED; ANASTOMOSIS; ARTICLE; BLEEDING; BYPASS SURGERY; COMPARATIVE STUDY; DIABETES MELLITUS; FEMALE; FOLLOW UP; GANGRENE; GRAFT PATENCY; HOSPITALIZATION; HUMAN; LEG ARTERY; LIMB SALVAGE; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; OPERATION DURATION; POPLITEAL ARTERY; POSTOPERATIVE HEMORRHAGE; PROSPECTIVE STUDY; REVASCULARIZATION; SAPHENOUS VEIN; VEIN GRAFT;

AGED; DIABETES COMPLICATIONS; DIABETIC ANGIOPATHIES; FEMALE; FOLLOW-UP STUDIES; GANGRENE; HUMANS; ISCHEMIA; LEG; MALE; PATIENT SELECTION; POPLITEAL ARTERY; SAPHENOUS VEIN; SURVIVAL RATE;

EID: 77749273834     PISSN: 03011526     EISSN: None     Source Type: Journal    
DOI: 10.1024/0301-1526/a000006     Document Type: Article

References (31)

1. Akbari CM, Pomposelli FB, Jr., Gibbons GW, Campbell DR, Pulling MC, Mydlarz D, Lo-Gerfo FW. Lower extremity revascularization in diabetes: late observations. Arch Surg 135 (4): 452-6, 2000.
2. Apelqvist J. Wound healing in diabetes. Outcome and costs. Clin Podiatr Med Surg 15 (1): 21-39, 1998.
3. Apelqvist J, Agardh CD. The association between clinical risk factors and outcome of diabetic foot ulcers. Diabetes Res Clin Pract 18 (1): 43-53, 1992.
4. Apelqvist J, Castenfors J, Larsson J, Stenstrom A, Agardh CD. Prognostic value of systolic ankle and toe blood pressure levels in outcome of diabetic foot ulcer. Diabetes Care 12 (6): 373-8, 1989.
5. Apelqvist J, Larsson J, Agardh CD. Medical risk factors in diabetic patients with foot ulcers and severe peripheral vascular disease and their influence on outcome. J Diabetes Complications 6 (3): 167-74, 1992.
6. Bakken AM, Palchik E, Hart JP, Rhodes JM, Saad WE, Davies MG. Impact of diabetes mellitus on outcomes of superficial femoral artery endoluminal interventions. J Vasc Surg 46 (5): 946-58; discussion 958, 2007.
7. Bandyk DF, Schmitt DD, Seabrook GR, Adams MB, Towne JB. Monitoring functional patency of in situ saphenous vein bypasses: the impact of a surveillance protocol and elective revision. J Vasc Surg 9 (2): 286-96, 1989.
8. Bergamini TM, Towne JB, Bandyk DF, Seabrook GR, Schmitt DD. Experience with in situ saphenous vein bypasses during 1981 to 1989: determinant factors of long-term patency. J Vasc Surg 13 (1): 137-47; discussion 148-9, 1991.
9. Clark TW, Groffsky JL, Soulen MC. Predictors of long-term patency after femoropopliteal angioplasty: results from the STAR registry. J Vasc Interv Radiol 12 (8): 923-33, 2001.
10. Danielsson G, Albrechtsson U, Norgren L, Danielsson P, Ribbe E, Thorne J, Zdanowski Z. Percutaneous transluminal angioplasty of crural arteries: diabetes and other factors influencing outcome. Eur J Vasc Endovasc Surg 21 (5): 432-6, 2001.
11. Davies AH, Cole SE, Magee TR, Scott DJ, Baird RN, Horrocks M. The effect of diabetes mellitus on the outcome of angioplasty for lower limb ischaemia. Diabet Med 9 (5): 480-1, 1992.
12. Davies AH, Hawdon AJ, Sydes MR, Thompson SG. Is duplex surveillance of value after leg vein bypass grafting? Principal results of the Vein Graft Surveillance Randomised Trial (VGST). Circulation 112 (13): 1985-91, 2005.
13. Davies MG, Kim JH, Klyachkin ML, Barber L, Dalen H, Svendsen E, Carson CC, 3rd, Hagen PO. Diabetes mellitus and experimental vein graft structure and function. J Vasc Surg 19 (6): 1031-43, 1994.
14. DeRubertis BG, Pierce M, Ryer EJ, Trocciola S, Kent KC, Faries PL. Reduced primary patency rate in diabetic patients after percutaneous intervention results from more frequent presentation with limb-threatening ischemia. J Vasc Surg 47 (1): 101-8, 2008.
15. Diehm N., Rohrer S., Baumgartner I., Keo H., Do D., Kalka C., Distribution pattern of infrageniculate arterial obstructions in patients with diabetes mellitus and renal insufficiency - implications for revascularization. VASA 2008(37) 3: 265-73
16. Hakaim AG, Gordon JK, Scott TE. Early outcome of in situ femorotibial reconstruction among patients with diabetes alone versus diabetes and endstage renal failure: analysis of 83 limbs. J Vasc Surg 27 (6): 1049-54; discussion 1054-5, 1998.
17. Hertzer NR, Bena JF, Karafa MT. A personal experience with the influence of diabetes and other factors on the outcome of infrainguinal bypass grafts for occlusive disease. J Vasc Surg 46 (2): 271-9, 2007.
18. Jensen LP, Schroeder TV, Lorentzen JE. In situ saphenous vein bypass surgery in diabetic patients. Eur J Vasc Surg 6 (5): 533-9, 1992.
19. Kalman PG, Johnston KW. Predictors of long-term pa tient survival after in situ vein leg bypass. J Vasc Surg 25 (5): 899-904, 1997.
20. Kudo T, Chandra FA, Kwun WH, Haas BT, Ahn SS. Changing pattern of surgical revascularization for critical limb ischemia over 12 years: endovascular vs. open bypass surgery. J Vasc Surg 44 (2): 304-13, 2006.
21. Laxdal E, Eide GE, Wirsching J, Jenssen GL, Jonung T, Pedersen G, Amundsen SR, Dregelid E, Aune S. Homocysteine levels, haemostatic risk factors and patency rates after endovascular treatment of the above-knee femoro-popliteal artery. Eur J Vasc Endovasc Surg 28 (4): 410-7, 2004.
22. Lazaris AM, Tsiamis AC, Fishwick G, Bolia A, Bell PR. Clinical outcome of primary infrainguinal subintimal angioplasty in diabetic patients with critical lower limb ischemia. J Endovasc Ther 11 (4): 447-53, 2004.
23. Menzoian JO, LaMorte WW, Paniszyn CC, McBride KJ, Sidawy AN, LoGerfo FW, Connors ME, Doyle JE. Symptomatology and anatomic patterns of peripheral vascular disease: differing impact of smoking and diabetes. Ann Vasc Surg 3 (3): 224-8, 1989.
24. Raines JK, Darling RC, Buth J, Brewster DC, Austen WG. Vascular laboratory criteria for the management of peripheral vascular disease of the lower extremities. Surgery 79 (1): 21-9, 1976.
25. Rueda CA, Nehler MR, Perry DJ, McLafferty RB, Casserly IP, Hiatt WR, Peyton BD. Patterns of artery disease in 450 patients undergoing revascularization for critical limb ischemia: implications for clinical trial design. J Vasc Surg 47 (5): 995-9; discussion 999-1000, 2008.
26. Sigala F, Georgopoulos S, Langer S, Baunach C, Papalambros E, Sigalas K, Bramis J, Bakoyiannis C, Bastounis E, Hepp W. Outcome of infrainguinal revascularization for critical limb ischemia in diabetics with end stage renal disease. Vasa 35 (1): 15-20, 2006.
27. Sigala F, Menenakos C, Sigalas P, Baunach C, Langer S, Papalambros E, Hepp W. Transluminal angioplasty of isolated crural arterial lesions in diabetics with critical limb ischemia. Vasa 34 (3): 186-91, 2005.
28. Ubbink DT, Tulevski, II, Legemate DA, Jacobs MJ. Diabetes mellitus is not a contra-indication for peripheral vascular intervention in patients with leg ischemia. Vasa 26 (1): 39-42, 1997.
29. Wagner FW, Jr. The dysvascular foot: a system for diagnosis and treatment. Foot Ankle 2 (2): 64-122, 1981.
30. Wolfle KD, Bruijnen H, Loeprecht H, Rumenapf G, Schweiger H, Grabitz K, Sandmann W, Lauterjung L, Largiader J, Erasmi H, Kasprzak PM, Raithel D, Allenberg JR, Lauber A, Berlakovich GM, Kretschmer G, Hepp W, Becker HM, Schulz A. Graft patency and clinical outcome of femorodistal arterial reconstruction in diabetic and non-diabetic patients: results of a multicentre comparative analysis. Eur J Vasc Endovasc Surg 25 (3): 229-34, 2003.
31. Zeller T., Sixt S., Rastan A., New techniques for endovascular treatment of peripheral artery disease with focus on chronic critical limb ischemia. VASA 2009 (38) 1: 3-12